TETIG 250 NE oldatos injekció Humán tetanusz elleni immunglobulin TETIG 500 NE oldatos injekció Humán tetanusz elleni immunglobulin Gamma-Tet P 250 UI/1 ml soluzione iniettabile per uso intramuscolare Gamma-Tet P 500 UI/2 ml soluzione iniettabile per uso intramuscolare Tetagam ® P- Fertigspritze Tetagam P solução injectável 250 U.I./ml GAMMATETANOS 250 UI / 2 ml, solution injectable (IM) Tetagam P 250 i.e. raztopina za injiciranje Tetagam P Ενέσιμο διάλυμα Tetagam P Solution for injection for intramuscular use Tetagam® P Injektionslösung zur intramuskulären Anwendung
not available
OGYI-T-9471/01
HU
not available
OGYI-T-9471/02
not available
022635066
HUMAN BIOPLAZMA MANUFACTURING AND TRADING LLC HUMAN BIOPLAZMA MANUFACTURING AND TRADING LLC CSL BEHRING GMBH
Mar 8, 2018 - Treatment of uterine fibroids. Haematology. New medicines authorised. ⢠Adynovi (rurioctocog alfa pegol). Treatment and prevention of bleeding in patients with haemophilia A. New information on authorised medicines. ⢠Feraccru (ferr
Treatment of cystine crystal deposits in the eye. New information on authorised medicines. Lucentis (ranibizumab) - change in indication. Treatment of visual ...
The new EudraVigilance system and the electronic reporting of individual case ... the ISO/ICH E2B(R3) format: hands-on training course - October 2017 ... granted a conditional marketing authorisation on the basis of less complete clinical data ...
PCWP and HCPWP joint meeting - Sept 2016 - meeting documents. ⢠Workshop on identifying opportunities for 'big data' in medicines development and ...
Used for the management of hypovolaemia (low blood volume) caused by acute (sudden) blood loss .... EMA's Business Continuity Plan for Brexit published.
RSS feeds you need one of the following: a modern web browser; a web-based news reader or a ... Withdrawal of applications for new medicines .... fifth annual regulatory conference on optimising the development of advanced therapies to.
RSS feeds you need one of the following: a modern web browser; a web-based news reader or a desktop news reader. For a list of RSS readers please refer to ...
RSS feeds you need one of the following: a modern web browser; a web-based news reader or a desktop news reader. For a list of RSS readers please refer to ...
For a list of RSS readers please refer to our RSS guide and follow the instructions .... granted a conditional marketing authorisation on the basis of less complete ...
Apr 28, 2017 - 2. The United Kingdom will then become a 'third country'. 3. Preparing for the withdrawal is therefore not just a matter for EU and national authorities, but also for private parties. In view of the considerable uncertainties, in parti
May 30, 2017 - Pharmaceutical companies are invited to present their pre-clinical data pertaining to ... patients per year, as many questions about the best use of ALK ... of knowledge and evidence to support the planning and regulatory.
monitoring. 5. Guidelines. 5. Scientific .... Updated list of medicinal products under additional monitoring. Other information. Guidelines. Guidelines open for consultation ... CHMP -applications for new human medicines under evaluation: April 2016
HUMAN MEDICINES. HIGHLIGHTS. Issue 105. December 2017. This newsletter is addressed primarily to organisations representing patients, consumers and healthcare professionals. It provides a summary of key information relating to medicines for human use
Jan 29, 2018 - professionals. It provides a summary of key information relating to medicines for human use published ... Information is selected based on recommendations from consulted patients, consumers and healthcare professionals, and .... 30 Chu
desktop news reader. For a list of RSS readers please .... CHMP -applications for new human medicines under evaluation: April 2016. ⢠2016 work plan for the ...
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...
4 days ago - EMA/CAT/426129/2018. Page 2/17. Table of contents. 1. Introduction. 5. 1.1. Welcome and declarations of interest of members, alternates and ...
Sep 8, 2016 - 3-year report on Pharmacovigilance activities. Helen Lee, European Commission. â¢. Scanning the horizon for 2016 â 2018. Peter Arlett, EMA.
On arriving for your meeting at 30 Churchill Place, please report to reception where you will be issued with an access pass. This pass will allow you to enter our industry lounge, which you are welcome to utilise during your visit. The industry loung
Jan 26, 2017 - is an antiparasitic medicine that treats the Varroa mite infestation in honey-bee colonies, which is considered to be the most significant parasitic ...
